This fact, together with the important role of certain cellular targets of dasatinib in the regulation of the dissemination and seeding of breast cancer cells (Zhang et al., 2013), led us to explore the effect of this kinase inhibitor in NRG‐induced MMP13 upregulation. Here, MMP13 is linked to breast carcinoma.